Meet Our Team

Toronto, Ontario, Canada | He/Him

Michael Haichin, PharmD, BCMAS

Dr. Michael Haichin has longstanding fascination about drugs that straddle the drug/medicine divide. This interest led him to pursue a B.Sc in Pharmacology from McGill University, followed by a PharmD from the University of Toronto. When he is not working in Medical Affairs in the pharmaceutical industry, he aims to provide accurate and insightful information about psychedelics as a Medical Advisor to Psychedelic Alpha and the Lead Editor of Psychedelic Science Review.

Portland, Oregon, USA | She/Her

Emily Kulpa, PharmD

Dr. Kulpa is a co-founder of the Psychedelic Pharmacists Association. She worked as the Director of Medical Screening at Synthesis Institute, a legal psilocybin retreat center in the Netherlands and as Head Pharmacist & Research Associate at the UTM Psychedelic Studies Research Program (PSRP) and Toronto Centre for Psychedelic Science (TCPS). Through these experiences Dr. Kulpa has gained specialized knowledge in psychedelic compounds, specifically psilocybin. 

Prior to joining the psychedelic industry she worked as a clinical pharmacist at a managed care organization. She specialized in medication therapy management, chronic disease management, and led medication adherence programs for Medicare Part D Star ratings.

Pittsburgh, Pennsylvania, USA | He/Him

Sa’ed Al-Olimat, PharmD

Sa’ed Al-Olimat, PharmD is a Taiwanese-Jordanian first generation American immigrant. He is a licensed pharmacist and educator of psychedelic medicine. He has worked with pharmaceutical companies, prescriber clinics, hospice and palliative care organizations, insurance groups, and other settings to enhance patient care.

Sa’ed is a community-pharmacy manager and mental health advocate. His passion in advancing mental health outcomes led him to investigating psilocybin and other classical psychedelic compounds as tools for mental, spiritual, and emotional support.

Sa’ed serves as a Co-Founder of the Psychedelic Pharmacists Association, Board Director of the Allegheny County Pharmacists Association, and Founder of PsiloHealth. He has also served as the Vice President of the Psychedelic Club of Pittsburgh and Founder of the Pittsburgh Psychedelic Society community meet-up.

In his free time, he enjoys socializing with friends, practicing Brazilian Jiu Jitsu, and watching anime.

Los Angeles, California, USA| He/Him

Kevin Lanzo, PharmD

Kevin is a co-founder of the Psychedelic Pharmacists Association and a clinical scientist working in the pharmaceutical industry to develop novel psychiatric treatments for mental health disorders. He is a graduate of the UNC Chapel Hill Eshelman School of Pharmacy, and completed a 2 year postdoctoral industry fellowship program with Genentech, in partnership with Rutgers University.

Kevin has a longstanding interest in researching the utility of psychedelic medicines, such as MDMA and psilocybin, for therapeutic use. His long-term goal is to lead development of clinical trials of psychedelic-assisted psychotherapy in-line with the FDA approval pathway. He is dedicated to advocacy for harm reduction, diversity in clinical trials, experiential treatments, reciprocity, and for clinical psychedelic research as a whole, having given multiple presentations on these topics to hundreds of people in a variety of audiences across clinical, industry, and academic settings.

“Pharmacists have a critical role to play in the psychedelic renaissance as scientific communicators. Our training gives us the skills to take the complex scientific data gleaned from clinical studies and translate it to language that patients, and other healthcare providers, can more easily understand.”

Broomfield, Colorado, USA| She/Her

Kristin Speer, PharmD, BCPS

Dr. Kristin Speer is a co-founder of the Psychedelic Pharmacist Association. In 1999, Kristin witnessed the horrific massacre unfold at Columbine, which was in the same neighborhood as Kristin’s high school. She subsequently shared her classrooms with displaced Columbine students, learning more about their stories, trauma and healing. This event sparked her interest in mental health and palliative care.

As a pharmacist, Kristin has practiced for nearly a decade in end-of-life and palliative care within the PBM environment. There, physicians and other prescribers consulted Kristin and her team on how to manage complex patients with distressing symptoms. Kristin often recommended and designed ketamine regimens due to the medication’s rapid acting effects on depression, anxiety and pain. Through her work in this field, she was introduced to the potential of other psychedelic therapies for palliative care and mental health.

Through the Psychedelic Pharmacists Association, Kristin aims to create a trusted source of psychedelic pharmacy curriculum for pharmacy schools across the nation, and to advocate for the expansion of psychedelic use in palliative care.

Kristin is an entrepreneur. She established a consulting business that designs and manages drug regimens for psychiatric conditions and pain. She is currently developing visual communication solutions and patient care tools for clients within various health industries and is co-producing a retail pharmacy documentary.

California, USA

Dr. Victoria Hale

Dr. Victoria Hale, PhD, BSPharm is a pharmaceutical scientist/executive and global health social entrepreneur. She was founder and CEO of two successful nonprofit pharmaceutical companies, OneWorld Health (2000) and Medicines360 (2009). She has previously served as Chair of the Board of Directors at MAPS, and CEO of Sacred Medicines, PBC. She is a MacArthur Fellow, was inducted into the U.S. National Academy of Medicine, has been recognized as an outstanding global social entrepreneur by Skoll, Ashoka and Schwab Foundations. Her drug development experience was obtained at the FDA and Genentech, Inc. She earned her Ph.D. in Pharmaceutical Chemistry from University of California, San Francisco (UCSF) and is presently Adjunct Professor of Bioengineering and Experimental Therapeutics.

California, USA

Dr. Kelan Thomas

Dr. Kelan Thomas, PharmD, MS, BCPP, BCPS is an Associate Professor of Clinical Sciences at Touro University California College of Pharmacy and Board Certified Psychiatric Pharmacist with outpatient behavioral health practice sites in the San Francisco Bay Area. He has conducted clinical research related to adverse drug reactions and pharmacogenomics with the goal of optimizing pharmacotherapy for mental health clients. In 2017, he completed the California Institute of Integral Studies Certificate in Psychedelic-Assisted Therapies and Research training program, began publishing psychedelic science articles and book chapters, while also collaborating on psychedelic clinical trials at the University of California, San Francisco.

Oregon, USA

Dr. Regina Moore

Dr. Regina Moore, PharmD is a co-founder of The Psychedelic Pharmacists Association and served on the Psychedelic Pharmacist’s Association Board of Directors from inception to July of 2023. She is a leader, educator, and advocate for the growing psychedelic ecosystem as well as a community-building expert, writer, entrepreneur, and personal finance enthusiast. Regina is also the mother of a son with cancer, mycophile, and artist.

After more than a decade of pharmacy practice, Regina now works as a consultant and focuses on her businesses to bring meaningful change to the world, while maintaining a small footprint in community pharmacy.  Communities and associations are an ongoing focus of her career, having previously served on the NCPA National Student Advisory Committee, the New Mexico Pharmacists Association Executive Council, and remains an ongoing member of the Oregon Pharmacy Coalition and Oregon Pharmacy Association. 

Regina was involved with Oregon’s Measure 109 (adult psilocybin access) rollout including being a member of the Rules and Advisory Committee. She is also active in interfacing with community groups to help represent and advocate for their needs as part of the rule-making process. She’s got a knack for mushroom foraging as well and enjoys learning and bridging mycology and psychedelic interests. 

Outside of her work in psychedelics, Regina manages her business and community as co-founder of Women’s Personal Finance. WPF is a thriving and award winning community devoted to helping women and non-binary folks meet their financial goals and establish meaningful connections and relationships.

Wisconsin, USA

Dr. Cody Wenthur

Dr. Cody Wenthur, PharmD, PhD, is an assistant professor at UW-Madison’s School of Pharmacy. He is a founding director of the first-of-its-kind Psychoactive Pharmaceutical Investigation Master’s of Science program, which prepares students to research the therapeutic applications of psychedelics and other psychoactive substances. He also leads the Wenthur Laboratory at UW-Madison’s School of Pharmacy, where they are focused on improving our understanding of the basis for beneficial and detrimental effects of opioids, cannabinoids, psychedelics, and other neuroplasticity-inducing approaches in the context of novel therapeutic approaches for promoting and maintaining mental health.